Suppr超能文献

使用维拉帕米和依那普利治疗的反应性和无反应性高血压患者的应激反应性。

Stress reactivity in responder and non-responder hypertensives treated with verapamil and enalapril.

作者信息

Nazzaro P, Manzari M, Merlo M, Triggiani R, Scarano A M, Lasciarrea A, Marella N, Pirrelli A

机构信息

Department of Biomedical Science and Human Oncology, University of Bari, Italy.

出版信息

Riv Eur Sci Med Farmacol. 1995 Jul-Aug;17(4):105-13.

PMID:8545563
Abstract

Hypertension was found to be associated with sympathetic overdrive but it is still debated if the antihypertensive agents can differently affect the stress response in hypertensive subjects. Through a psychophysiological study, we evaluated the effect of verapamil (V) and enalapril (E), both as monotherapy and association. Office BP was successfully reduced (< 145/90 mmHg) in 11 patients treated with V (V-Resp) and in 10 patients treated with E (E-Resp). Both the drugs were prescribed in 9 patients (V+E) who did not sufficiently lower their blood pressure (N-Resp) with monotherapy. Patients performed three stressors (color word stroop, cold pressor and handgrip). Extracardiovascular and hemodynamic functions were measured during baseline, stress and recovery periods. The response was evaluated adding the changes occurred in every phase of the psychophysiological session. This was performed before run-in and after any modification of the therapeutic intervention. The emotional arousal (phrontalis muscular contraction, skin conductance, peripheral temperature) was reduced when BP was normal. No change in BP reactivity was found. HR response decreased in V-Resp and cardiac output increased in E-Resp while the vascular reaction was restrained in E-Resp and V-Resp. This was reduced also in N-Resp when they assumed V+E and normalized their arterial pressure. The findings indicate that the sympathetic reactivity may be modified by the therapy. In particular, verapamil restrained the cardiac stress response without lowering the cardiac output and was advantageously associated with enalapril to control the psychophysiological response in more resistant hypertensive patients.

摘要

高血压被发现与交感神经过度兴奋有关,但抗高血压药物是否会对高血压患者的应激反应产生不同影响仍存在争议。通过一项心理生理学研究,我们评估了维拉帕米(V)和依那普利(E)单药治疗及联合治疗的效果。11例接受V治疗的患者(V反应组)和10例接受E治疗的患者(E反应组)的诊室血压成功降低(<145/90 mmHg)。9例单药治疗血压降低不充分的患者(无反应组)同时服用了这两种药物(V+E)。患者进行了三项应激测试(色词斯特鲁普测试、冷加压测试和握力测试)。在基线期、应激期和恢复期测量心血管外和血流动力学功能。通过累加心理生理过程各阶段发生的变化来评估反应。这在导入期前以及治疗干预的任何改变后进行。当血压正常时,情绪唤醒(额肌收缩、皮肤电导、外周温度)降低。未发现血压反应性有变化。V反应组的心率反应降低,E反应组的心输出量增加,而E反应组和V反应组的血管反应受到抑制。当无反应组服用V+E并使动脉血压正常化时,这种情况也有所减轻。研究结果表明,治疗可能会改变交感神经反应性。特别是,维拉帕米在不降低心输出量的情况下抑制心脏应激反应,并且与依那普利联合使用有利于控制更难治性高血压患者的心理生理反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验